US4077407A
(en)
*
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
US4445885A
(en)
*
|
1977-02-16 |
1984-05-01 |
Unitika, Ltd. |
Insulin releasing supplier
|
US4519909A
(en)
*
|
1977-07-11 |
1985-05-28 |
Akzona Incorporated |
Microporous products
|
US4159720A
(en)
*
|
1977-11-28 |
1979-07-03 |
Burton Andrew F |
Infusion of liquids into tissue
|
US4304672A
(en)
*
|
1978-04-04 |
1981-12-08 |
Sbr Lab, Inc. |
Stored blood and liquid system pH control method and apparatus
|
NZ192673A
(en)
*
|
1979-02-02 |
1984-07-06 |
Merck & Co Inc |
Ophthalmic compositions for lowering intraocular pressure
|
US4235236A
(en)
*
|
1979-02-12 |
1980-11-25 |
Alza Corporation |
Device for dispensing drug by combined diffusional and osmotic operations
|
US4357236A
(en)
*
|
1979-05-17 |
1982-11-02 |
Borg-Warner Corporation |
Automatic addition of a corrosion inhibitor to a coolant system by osmotic pressure
|
EP0033042B1
(en)
*
|
1980-01-28 |
1984-08-22 |
Merck & Co. Inc. |
Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
|
IE50901B1
(en)
*
|
1980-03-04 |
1986-08-06 |
Merck & Co Inc |
Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
|
JPS57140710A
(en)
*
|
1981-02-24 |
1982-08-31 |
Shionogi & Co Ltd |
Capsule agent for rectal administration
|
WO1982000096A1
(en)
*
|
1980-07-09 |
1982-01-21 |
Maren T |
Process for reducing intraocular pressure
|
US4300558A
(en)
*
|
1980-07-18 |
1981-11-17 |
Alza Corporation |
Self-driven fluid dispenser
|
US4439195A
(en)
*
|
1980-10-14 |
1984-03-27 |
Alza Corporation |
Theophylline therapy
|
US4364385A
(en)
*
|
1981-03-13 |
1982-12-21 |
Lossef Steven V |
Insulin delivery device
|
US4484921A
(en)
*
|
1982-02-01 |
1984-11-27 |
Alza Corporation |
Theophylline therapy utilizing osmotic delivery
|
JPS5931701A
(ja)
*
|
1982-08-16 |
1984-02-20 |
Nitto Electric Ind Co Ltd |
液状活性物質含有膜及びその製造方法
|
US4443428A
(en)
*
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
US4478596A
(en)
*
|
1982-11-26 |
1984-10-23 |
Michelson Paul E |
Delivery system for physiologically active agents
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
IE53703B1
(en)
*
|
1982-12-13 |
1989-01-18 |
Elan Corp Plc |
Drug delivery device
|
US4722937A
(en)
*
|
1984-06-29 |
1988-02-02 |
Joseph Jacob |
Antitoxin vaginal products and catamenials
|
US4585792A
(en)
*
|
1983-05-05 |
1986-04-29 |
Technology Unlimited Inc. |
Protective additive to vaginal products and catamenials
|
US4722936A
(en)
*
|
1983-05-05 |
1988-02-02 |
Joseph Jacob |
Deodorization vaginal products and catamenials
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US4503030A
(en)
*
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4751071A
(en)
*
|
1983-12-01 |
1988-06-14 |
Alza Corporation |
Composition comprising salbutamol
|
US4777049A
(en)
*
|
1983-12-01 |
1988-10-11 |
Alza Corporation |
Constant release system with pulsed release
|
US4851229A
(en)
*
|
1983-12-01 |
1989-07-25 |
Alza Corporation |
Composition comprising a therapeutic agent and a modulating agent
|
GB2150830B
(en)
*
|
1983-12-05 |
1987-08-19 |
Alza Corp |
Drug dispenser
|
US4761159A
(en)
*
|
1984-01-23 |
1988-08-02 |
Lewis Knox |
Method of chemical deodorization of articles and solutions used in medical and biological procedures
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4800056A
(en)
*
|
1984-03-21 |
1989-01-24 |
Alza Corporation |
Process for making dispenser with cooperating elements
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4615698A
(en)
*
|
1984-03-23 |
1986-10-07 |
Alza Corporation |
Total agent osmotic delivery system
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
US4743247A
(en)
*
|
1984-08-13 |
1988-05-10 |
Alza Corporation |
Process for manufacturing dosage form
|
GB8422876D0
(en)
*
|
1984-09-11 |
1984-10-17 |
Secr Defence |
Silicon implant devices
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4693886A
(en)
*
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
US4655766A
(en)
*
|
1985-08-01 |
1987-04-07 |
Alza Corporation |
Fluid imbibing pump with self-regulating skin patch
|
US4756314A
(en)
*
|
1985-10-28 |
1988-07-12 |
Alza Corporation |
Sweat collection patch
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
AU592629B2
(en)
*
|
1986-01-31 |
1990-01-18 |
Whitby Research, Inc. |
Compositions comprising 1-substituted azacycloalkanes and their uses
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4927632A
(en)
*
|
1986-06-26 |
1990-05-22 |
Alza Corporation |
Selective pulsed drug delivery system
|
US4786500A
(en)
*
|
1986-06-26 |
1988-11-22 |
Alza Corporation |
Programmable agent delivery system
|
US4885868A
(en)
*
|
1986-12-03 |
1989-12-12 |
Cornell Research Foundation, Inc. |
Banding techniques for plant propagation
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
US4832690A
(en)
*
|
1987-01-23 |
1989-05-23 |
Baxter International Inc. |
Needle-pierceable cartridge for drug delivery
|
US4801461A
(en)
*
|
1987-01-28 |
1989-01-31 |
Alza Corporation |
Pseudoephedrine dosage form
|
US4915952A
(en)
*
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
US5023076A
(en)
*
|
1987-02-27 |
1991-06-11 |
Alza Corporation |
Lamina comprising carboxyvinyl polymer
|
US4731122A
(en)
*
|
1987-03-30 |
1988-03-15 |
Alza Corporation |
Process for manufacturing a thermoplastic molding composition
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4795641A
(en)
*
|
1987-08-20 |
1989-01-03 |
Eastman Kodak Company |
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
GB8820353D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
US5612059A
(en)
*
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5019396A
(en)
*
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US6361795B1
(en)
*
|
1989-09-05 |
2002-03-26 |
Alza Corporation |
Method for lowering blood glucose
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5112614A
(en)
*
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5200197A
(en)
*
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5190763A
(en)
*
|
1990-05-07 |
1993-03-02 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
US5221536A
(en)
*
|
1990-05-07 |
1993-06-22 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
US5192550A
(en)
*
|
1990-05-07 |
1993-03-09 |
Alza Corporation |
Dosage form for treating central nervous system disorders
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
DK0542926T3
(da)
*
|
1990-08-07 |
1995-05-15 |
Pfizer |
Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
|
DK0550641T3
(da)
*
|
1990-09-28 |
1994-08-22 |
Pfizer |
Dispenseringsanordning indeholdende et hydrofobt medium
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
IT1255522B
(it)
*
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6129930A
(en)
*
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US20080045573A1
(en)
*
|
1993-09-20 |
2008-02-21 |
Bova David J |
Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
|
US6080428A
(en)
*
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5773021A
(en)
*
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
US5525279A
(en)
*
|
1994-04-04 |
1996-06-11 |
Sekisui Kagaku Kogyo K.K. |
Method of forming a granulocyte adsorbing carrier and granulocyte remover
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5595759A
(en)
*
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
IT1282576B1
(it)
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
ES2195151T3
(es)
|
1996-06-18 |
2003-12-01 |
Alza Corp |
Dispositivo de mejora de aporte o de muestreo de agentes transdermicos.
|
US5800624A
(en)
*
|
1996-10-22 |
1998-09-01 |
University Of Notre Dame |
Membrane process for separating carbohydrates
|
US6110498A
(en)
*
|
1996-10-25 |
2000-08-29 |
Shire Laboratories, Inc. |
Osmotic drug delivery system
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
IN186245B
(nl)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
ES2172944T3
(es)
|
1997-12-05 |
2002-10-01 |
Alza Corp |
Forma de dosificacion osmotica que comprende un primer y un segundo revestimiento.
|
TR200001828T2
(tr)
*
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid dozaj şekillerinin kötüye kullanımını önlemeye yönelik bir yöntem.
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
SI1685839T1
(sl)
|
1997-12-22 |
2013-08-30 |
Euro-Celtique S.A. |
Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
|
AU1623099A
(en)
*
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
AU1238500A
(en)
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
CA2360938C
(en)
|
1999-02-02 |
2008-01-08 |
Warren Oliver Haggard |
Controlled release composite
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
CA2393601A1
(en)
*
|
1999-12-09 |
2001-06-14 |
Alza Corporation |
Antiviral medication
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
AR030557A1
(es)
*
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
MXPA03003994A
(es)
|
2000-11-03 |
2004-09-10 |
Andrx Labs Llc |
Composiciones de metformina de liberacion controlada.
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
EP2277556B1
(en)
|
2001-05-01 |
2016-04-20 |
A. V. Topchiev Institute of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
RU2276998C2
(ru)
*
|
2001-05-01 |
2006-05-27 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Гидрогелевые композиции
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8840918B2
(en)
*
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
EP2316394B1
(en)
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
DK1416842T3
(da)
|
2001-07-18 |
2009-03-16 |
Euro Celtique Sa |
Farmaceutiske kombinationer af oxycodon og naloxon
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030157168A1
(en)
*
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
CN1596100A
(zh)
*
|
2001-09-28 |
2005-03-16 |
麦克内尔-Ppc股份有限公司 |
可食用组合物及含可食用外壳的制剂
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US20030125714A1
(en)
*
|
2001-12-18 |
2003-07-03 |
Edgren David Emil |
Dosage form for time-varying patterns of drug delivery
|
EP1465592A2
(en)
*
|
2001-12-19 |
2004-10-13 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
CA2471081A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US7004171B2
(en)
*
|
2002-02-25 |
2006-02-28 |
Hi-Gienic Intra Vaginal Technologies Ltd. |
System for transvaginal drug delivery
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
KR20040098050A
(ko)
|
2002-04-05 |
2004-11-18 |
유로-셀띠끄 소시에떼 아노님 |
옥시코돈 및 날록손을 포함하는 약제학적 제제
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
RU2004134594A
(ru)
*
|
2002-04-29 |
2005-06-27 |
Алза Корпорейшн (Us) |
Способы и лекарственные формы для контролируемой доставки оксикодона
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
US7094427B2
(en)
*
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
US20060013875A1
(en)
*
|
2002-05-29 |
2006-01-19 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
IL165361A0
(en)
*
|
2002-05-31 |
2006-01-15 |
Alza Corp |
Dosage forms and compositions for osmotic deliveryof variable dosages of oxycodone
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
IL166023A0
(en)
*
|
2002-06-28 |
2006-01-15 |
Alza Corp |
Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
KR20120034211A
(ko)
|
2002-09-20 |
2012-04-10 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
UY28057A1
(es)
*
|
2002-10-31 |
2003-12-31 |
Alza Corp |
Formulacion y forma de dosificacion que provee mayor biodisponibilidad de los farmacos hidrófobos
|
CA2504038A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Alza Corporation |
Dosage form providing ascending release of liquid formulation
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
CN101797221B
(zh)
|
2002-12-13 |
2013-06-12 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
WO2004054568A1
(en)
*
|
2002-12-17 |
2004-07-01 |
Abbott Gmbh & Co. Kg |
Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
|
US7259186B2
(en)
*
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
US20080051411A1
(en)
*
|
2002-12-17 |
2008-02-28 |
Cink Russell D |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
ATE401866T1
(de)
*
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
TWI347201B
(en)
*
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
US7611480B2
(en)
*
|
2003-04-24 |
2009-11-03 |
Levy Mark M |
Gastrointestinal bioreactor
|
AU2004249295A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Viral Genomix, Inc. |
Compositions for and methods for treating HIV
|
ES2379466T3
(es)
*
|
2003-06-26 |
2012-04-26 |
Psivida Us, Inc. |
Sistema de suministro de fármacos de liberación sostenida bioerosionables
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
JP5229768B2
(ja)
|
2003-06-26 |
2013-07-03 |
シヴィダ・ユーエス・インコーポレイテッド |
In−Situゲル化薬物輸送システム
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
EP2298303A1
(en)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
MXPA06003453A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
AU2004275816A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
EP1667652B1
(en)
*
|
2003-09-26 |
2007-05-30 |
ALZA Corporation |
Improved controlled release dosage form including a banded engine
|
CA2540045A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Dosage form for controlled release of an active agent formulation
|
MXPA06003452A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
|
JP2007524652A
(ja)
*
|
2003-09-26 |
2007-08-30 |
アルザ・コーポレーシヨン |
アルプラゾラムの制御送達のための浸透性投薬形態物
|
KR20060092255A
(ko)
*
|
2003-09-26 |
2006-08-22 |
알자 코포레이션 |
고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
|
EP1680083A1
(en)
*
|
2003-10-31 |
2006-07-19 |
ALZA Corporation |
Compositions and dosage forms for ehnanced absorption of iron
|
US20050095288A1
(en)
*
|
2003-11-03 |
2005-05-05 |
Andrx Labs, Llc |
Decongestant and expectorant tablets
|
TW200528144A
(en)
*
|
2003-11-14 |
2005-09-01 |
Alza Corp |
Controlled release of topiramate in liquid dosage forms
|
WO2005051325A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol compositions methods of treatment and delivery
|
US8734850B2
(en)
*
|
2003-11-25 |
2014-05-27 |
Flamel Technologies |
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
CA2550699A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms of topiramate
|
EP1701706A2
(en)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Novel drug compositions and dosage forms
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
US20060009425A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
US20050287212A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Liang-Chang Dong |
Oral delivery system comprising a drug/polymer complex
|
WO2006007351A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Squeeze controlled oral dosage form
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
CA2511212A1
(en)
*
|
2004-07-02 |
2006-01-02 |
Henkel Kommanditgesellschaft Auf Aktien |
Surface conditioner for powder coating systems
|
AU2005271259B2
(en)
|
2004-08-05 |
2012-01-19 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Adhesive composition
|
JP2008510000A
(ja)
*
|
2004-08-19 |
2008-04-03 |
アルザ・コーポレーシヨン |
制御放出性ナノ粒子有効薬剤配合物投与剤型品および方法
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
KR20070104884A
(ko)
|
2004-11-24 |
2007-10-29 |
메드포인트 헬쓰케어 인크. |
아젤라스틴을 포함하는 조성물 및 이의 사용 방법
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8252331B2
(en)
*
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
ATE413864T1
(de)
*
|
2005-01-27 |
2008-11-15 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
JP5704789B2
(ja)
*
|
2005-01-28 |
2015-04-22 |
ユーロ−セルティーク エス.エイ. |
耐アルコール性剤形
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
US7919453B2
(en)
*
|
2005-03-25 |
2011-04-05 |
Kimberly-Clark Worldwide, Inc. |
Dosage cap assembly for an applicator
|
US7993667B2
(en)
*
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
US7744556B2
(en)
*
|
2005-03-25 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Delivery tube assembly for an applicator
|
US7527614B2
(en)
|
2005-03-25 |
2009-05-05 |
Kimberly-Clark Worldwide, Inc. |
Protective tube for a medicated tampon
|
US9295289B2
(en)
*
|
2005-04-01 |
2016-03-29 |
Leslie Jane James |
Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
|
UA100966C2
(ru)
|
2005-04-08 |
2013-02-25 |
Эбботт Леборетриз |
Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
|
US20080152714A1
(en)
*
|
2005-04-08 |
2008-06-26 |
Yi Gao |
Pharmaceutical Formulations
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
WO2006113568A2
(en)
*
|
2005-04-19 |
2006-10-26 |
Alza Corporation |
Controlled delivery dosage form of tramadol and gabapentin
|
US7708726B2
(en)
*
|
2005-04-28 |
2010-05-04 |
Kimberly-Clark Worldwide, Inc. |
Dosage form cap for an applicator
|
RU2408368C2
(ru)
|
2005-06-27 |
2011-01-10 |
Биовэйл Лэборэториз Интернэшнл С.Р.Л. |
Препараты соли бупропиона с модифицированным высвобождением
|
US20070003624A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Shanbhag Anant R |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
EP1912622A2
(en)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US20070036929A1
(en)
*
|
2005-08-09 |
2007-02-15 |
The Boeing Company |
Thin film applique
|
MX2008002795A
(es)
*
|
2005-08-30 |
2009-02-25 |
Nicholas Piramal India Ltd |
Composicion farmaceutica de metformina de liberacion extendida y proceso para producirla.
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
CA2949643C
(en)
|
2005-09-27 |
2018-05-15 |
Tissuetech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US8187639B2
(en)
*
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
WO2007062266A2
(en)
|
2005-11-28 |
2007-05-31 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
US20070141118A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Damico Joyce A |
Layered dosage form for a medicated tampon assembly
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
WO2007106349A2
(en)
|
2006-03-10 |
2007-09-20 |
Neurogen Corporation |
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
|
CN101453993A
(zh)
*
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
WO2007112579A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Drug delivery composition
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
EP2532235A1
(en)
|
2006-09-22 |
2012-12-12 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
MX2009005478A
(es)
|
2006-11-27 |
2009-08-12 |
Lundbeck & Co As H |
Derivados de heteroarilamida.
|
KR20090091321A
(ko)
|
2006-11-28 |
2009-08-27 |
마리누스 파마슈티컬스 |
나노입자 제형, 이의 제조방법 및 이의 용도
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8895061B2
(en)
*
|
2007-03-02 |
2014-11-25 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
US20070172525A1
(en)
*
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
US20080064701A1
(en)
*
|
2007-04-24 |
2008-03-13 |
Ramesh Sesha |
Anti-diabetic combinations
|
WO2008116004A2
(en)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
US20090082315A1
(en)
*
|
2007-09-05 |
2009-03-26 |
Raif Tawakol |
Compositions and Methods for Controlling Cholesterol Levels
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
KR101607112B1
(ko)
|
2007-11-23 |
2016-03-29 |
그뤼넨탈 게엠베하 |
타펜타돌 조성물
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
US8551524B2
(en)
*
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
EP2283160A4
(en)
*
|
2008-05-07 |
2012-01-04 |
Wintherix Llc |
METHOD FOR IDENTIFYING WNT SIGNALING MODULATING COMPOUNDS IN CANCER CELLS
|
CA2724533C
(en)
*
|
2008-07-24 |
2014-07-29 |
Handa Pharmaceuticals, Llc |
Stabilized atypical antipsychotic formulation
|
TWI392673B
(zh)
|
2008-08-27 |
2013-04-11 |
Calcimedica Inc |
調控細胞內鈣離子濃度之化合物
|
US20100190752A1
(en)
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
EP2163240A1
(en)
|
2008-09-12 |
2010-03-17 |
Universita' Degli Studi Di Genova |
A method for the production of bioadhesive compact matrices
|
NZ592437A
(en)
|
2008-10-30 |
2013-03-28 |
Gruenenthal Chemie |
A dosage form comprising tapentadol and an opioid antagonist
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US20100233259A1
(en)
*
|
2008-12-12 |
2010-09-16 |
Pascal Grenier |
Dosage form of ropinirole
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CA2749933A1
(en)
*
|
2009-02-04 |
2010-08-12 |
Supernus Pharmaceuticals, Inc. |
Formulations of desvenlafaxine
|
EP3045043B1
(en)
|
2009-02-26 |
2020-04-29 |
Relmada Therapeutics, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
EP2405915B1
(en)
|
2009-03-10 |
2018-10-24 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
EP2421901B1
(en)
|
2009-04-24 |
2015-10-28 |
Tissue Tech, Inc. |
Compositions containing hc ha complex and methods of use thereof
|
CN102573811A
(zh)
|
2009-06-02 |
2012-07-11 |
陶氏环球技术有限责任公司 |
缓释剂型
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
WO2011097594A2
(en)
|
2010-02-08 |
2011-08-11 |
Kinagen, Inc. |
Therapeutic methods and compositions involving allosteric kinase inhibition
|
MX339192B
(es)
|
2010-03-24 |
2016-05-13 |
Amitech Therapeutic Solutions Inc |
Compuestos heterociclicos utiles para inhibicion de cinasa.
|
WO2011122524A1
(ja)
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
WO2011130455A1
(en)
|
2010-04-13 |
2011-10-20 |
Najib Babul |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
DK2563776T3
(en)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Relations that modulate intracellular calcium
|
AU2011248579A1
(en)
|
2010-04-27 |
2012-11-29 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20130259875A1
(en)
|
2010-05-11 |
2013-10-03 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of amyotrophic lateral sclerosis
|
MX2020004501A
(es)
|
2010-06-03 |
2021-11-09 |
Pharmacyclics Llc |
El uso de inhibidores de la tirosina quinasa de bruton (btk).
|
WO2012003968A1
(en)
|
2010-07-06 |
2012-01-12 |
Grünenthal GmbH |
Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
|
WO2012007159A2
(en)
|
2010-07-14 |
2012-01-19 |
Grünenthal GmbH |
Novel gastro-retentive dosage forms
|
CA2807537C
(en)
|
2010-08-05 |
2018-09-18 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
CN105435338B
(zh)
|
2010-08-05 |
2019-03-26 |
弗赛特影像4股份有限公司 |
用于药物输送的注入器装置和方法
|
PT2600812T
(pt)
|
2010-08-05 |
2021-11-09 |
Forsight Vision4 Inc |
Aparelho para tratar um olho
|
JP5916149B2
(ja)
|
2010-08-27 |
2016-05-11 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
MY166034A
(en)
|
2010-12-22 |
2018-05-21 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
EP2661264B1
(en)
|
2011-01-07 |
2018-12-05 |
Allergan, Inc. |
Melanin modification compositions and methods of use
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
US20130172424A1
(en)
|
2011-12-30 |
2013-07-04 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
FR2987264A1
(fr)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
Methodes et compositions pour le traitement des metastases cancereuses
|
MX2014011473A
(es)
|
2012-03-26 |
2014-12-08 |
Golden Biotechnology Corp |
Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.
|
JP2015528001A
(ja)
|
2012-07-11 |
2015-09-24 |
ティッシュテック,インク. |
Hc−ha/ptx3複合体を含む組成物およびその使用方法
|
AR091779A1
(es)
|
2012-07-16 |
2015-02-25 |
Rhodes Technologies |
Procedimiento para la sintesis mejorada de opioides
|
SG11201407988UA
(en)
|
2012-07-16 |
2015-01-29 |
Rhodes Technologies |
Process for improved opioid synthesis
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CA2892084C
(en)
|
2012-11-21 |
2020-11-10 |
Golden Biotechnology Corporation |
Methods and compositions for treating neurodegenerative diseases
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
US10232018B2
(en)
|
2013-03-14 |
2019-03-19 |
Mallinckrodt Ard Ip Limited |
ACTH for treatment of acute respiratory distress syndrome
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
EP2978393B1
(en)
|
2013-03-28 |
2023-12-27 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
JP2016521279A
(ja)
|
2013-04-30 |
2016-07-21 |
アッヴィ・インコーポレイテッド |
アトラセンタンを使用して脂質プロファイルを改善するための方法
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
EP3782614A1
(en)
|
2013-10-07 |
2021-02-24 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
EP3077388A1
(en)
|
2013-12-05 |
2016-10-12 |
Pharmacyclics, LLC |
Inhibitors of bruton's tyrosine kinase
|
MX2016009125A
(es)
|
2014-01-15 |
2017-02-02 |
Rhodes Tech |
Proceso para la sintesis mejorada de oximorfona.
|
MX2016009300A
(es)
|
2014-01-15 |
2017-04-13 |
Rhodes Tech |
Proceso para la sintesis mejorada de oxicodona.
|
US9962363B2
(en)
|
2014-02-10 |
2018-05-08 |
Patara Pharma, LLC |
Mast cell stabilizers treatment for systemic disorders
|
AU2015213681B2
(en)
|
2014-02-10 |
2020-03-12 |
Respivant Sciences Gmbh |
Mast cell stabilizers for lung disease treatment
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
US9474756B2
(en)
|
2014-08-08 |
2016-10-25 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
CN114587774B
(zh)
|
2014-11-10 |
2024-07-19 |
弗赛特影像4股份有限公司 |
治疗眼睛的系统
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
BR112017017729A2
(pt)
|
2015-02-20 |
2018-04-10 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
forma de dosagem oral de liberação controlada de agonista de receptor gaba
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
MX2017011018A
(es)
|
2015-02-27 |
2018-01-18 |
Curtana Pharmaceuticals Inc |
Inhibicion de la actividad de olig2.
|
US10342831B2
(en)
|
2015-05-20 |
2019-07-09 |
Tissuetech, Inc. |
Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
WO2017040617A1
(en)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
WO2017147146A1
(en)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists
|
MX2018012021A
(es)
|
2016-04-05 |
2019-01-24 |
Forsight Vision4 Inc |
Dispositivos de administracion de farmacos oculares implantables.
|
CA3024556A1
(en)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
EP3463576A4
(en)
|
2016-05-25 |
2020-01-15 |
Concentric Analgesics, Inc. |
PRODRUGS BY PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETIC AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
CN106317468A
(zh)
*
|
2016-08-23 |
2017-01-11 |
无锡市永亿精密铸造有限公司 |
一种用于超声波美容仪的复合材料
|
JP7028860B2
(ja)
|
2016-08-26 |
2022-03-02 |
カーテナ ファーマシューティカルズ,インク. |
Olig2活性の阻害
|
JP2019528320A
(ja)
|
2016-08-31 |
2019-10-10 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh |
特発性肺線維症による慢性咳の治療のためのクロモリン組成物
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
WO2018067341A1
(en)
|
2016-10-07 |
2018-04-12 |
Patara Pharma, LLC |
Cromolyn compositions for treatment of pulmonary fibrosis
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
JP7424637B2
(ja)
|
2017-11-10 |
2024-01-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ash1l分解剤及びそれを用いた治療方法
|
BR112020010053A2
(pt)
|
2017-11-21 |
2020-11-03 |
Forsight Vision4, Inc. |
aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo
|
US11324729B2
(en)
|
2017-12-07 |
2022-05-10 |
The Regents Of The University Of Michigan |
NSD family inhibitors and methods of treatment therewith
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
MX2020008527A
(es)
|
2018-02-16 |
2020-09-18 |
Esperion Therapeutics Inc |
Formulaciones de liberacion sostenida de acido bempedoico.
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
CN112533581B
(zh)
|
2018-06-07 |
2024-08-30 |
密歇根大学董事会 |
Prc1抑制剂及用其进行治疗的方法
|
US10717712B2
(en)
|
2018-07-27 |
2020-07-21 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
AU2020240015A1
(en)
|
2019-03-15 |
2021-10-07 |
Unicycive Therapeutics Inc. |
Nicorandil derivatives
|
WO2022010537A1
(en)
|
2020-07-10 |
2022-01-13 |
The Regents Of The University Of Michigan |
Gas41 inhibitors and methods of use thereof
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
JP2024531170A
(ja)
|
2021-08-11 |
2024-08-29 |
バイオメア フュージョン,インコーポレイテッド |
真性糖尿病に対するメニン-mll相互作用の共有結合性阻害剤
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
US11945785B2
(en)
|
2021-12-30 |
2024-04-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of FLT3
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|